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Introduction {#sec001}
============

*Hermetia illucens* L. (Diptera: Stratiomyidae) is a saprophytic insect whose larvae (BSFL) consume a wide range of organic wastes and convert them into biomass \[[@pone.0225873.ref001]\]. BSFL consuming livestock waste, such as pig manure, inhibit many associated zoonotic pathogen loads. For example, Liu et al. (2008) \[[@pone.0225873.ref002]\] determined BSFL can reduce *Escherichia coli* in dairy manure. Furthermore, Lalander et al. (2015) \[[@pone.0225873.ref003]\] discovered that BSFL reduce *Salmonella* spp. as well as viruses in organic wastes.

The mechanisms allowing BSFL to inhibit these zoonotic pathogens have been investigated. Park et al. (2015) \[[@pone.0225873.ref004]\] characterized an *H*.*illucens* defensin-like peptide which has activity against Gram-positive bacteria. Elhag et al. (2017) \[[@pone.0225873.ref005]\] identified seven gene fragments responsible for the production of three types of antimicrobial peptides. And, Zdybicka-Barabas et al. (2017) \[[@pone.0225873.ref006]\] determined *E*. *coli*-challenged BSFL had increased phenoloxidase, lysozyme and anti-Gram-positive bacterium activity.

At a much broader scale, insects rely on innate defense reactions to inhibit pathogens by producing antimicrobial peptides, phenoloxidase and H~2~O~2~. In *Drosophila* (Diptera: Drosophilidae), the Toll signaling pathway is mainly induced by Gram-positive bacteria and fungi \[[@pone.0225873.ref007]\]. In the sea urchin, *Strongylocentrotus intermedius*, petidoglycan and PolyI: C, but not LPS or ZOA, increased the expression of *SiTLR11*, which activated antifungal responses \[[@pone.0225873.ref008]\]. And, with mosquitoes (Diptera: Culicidae), the intestinal microbiota inhibits the development of *Plasmodium* spp. and other human pathogens through activation of the insect's basal immunity \[[@pone.0225873.ref009]\].

Toll-like receptors (TLRs) are proteins present in cellular membranes that are capable of recognizing invading foreign bodies (sentinel cells). They are a type I membrane receptor with an extracellular amino terminus and a conserved cytoplasmic region. TLRs recognize specific molecular structures associated with microbial pathogens, which serve to active innate and adaptive immune responses. With routine microbial burdens, such as those found in the absence of infection, the Toll pathway is at low activation levels. However, acute pathogenic bacterial infection transiently increases nuclear factor kappa B (NF-κB)-dependent innate immune signaling.

The insect gut immune system produces microbicidal ROS by dual oxidase (Duox) to restrict the proliferation of invading microorganisms. In addition, ROS is involved in regulating the healing process of intestinal trauma in insects and also functions as a signaling molecule to initiate other self-balancing signaling pathways \[[@pone.0225873.ref010]\]. The intestinal bacterial community also is associated with host immunity and bacteriostasis. The microbiota modulates anti-pathogen effects of some immune genes plausibly through activating basal immunity \[[@pone.0225873.ref009]\]. For example, in the oriental fruit fly, *Bactrocera dorsalis*, (Hendel) (Diptera: Tephritidae) ROS, which is induced by the *BdDuox* gene; a gene that plays a key role in intestinal bacterial community homeostasis \[[@pone.0225873.ref011]\].

ROS serves as an important immune mechanism for many insects against pathogenic microorganisms, such as bacteria, fungi, entomopathogenic viruses, and parasites \[[@pone.0225873.ref012]\]. For example, when mosquitoes are exposed to *Enterobacter* spp., known to naturally occur in mosquitoes, they are less likely to be infected by *Plasmodium* parasites. ROS activation is suspected to serve as a primary mechanism inhibiting development of the pathogen *in situ* \[[@pone.0225873.ref013]\].

The Duox regulatory pathway also contributes to maintaining gut--microbe homeostasis in insects \[[@pone.0225873.ref014]\]. Gut membrane-associated proteins, such as Mesh, regulate *Duox* expression through an arrestin-mediated MAPK/JNK/ERK phosphorylation cascade and play an important role in controlling the proliferation of gut bacteria. Expression of both *Mesh* and *Duox* is correlated with the gut bacterial microbiome, which, in mosquitoes, increases dramatically soon after acquisition of a blood meal \[[@pone.0225873.ref015]\].

Recent surveys of BSF gut microbiota revealed a diverse community dominated by Bacteroidetes and Proteobacteria \[[@pone.0225873.ref016],[@pone.0225873.ref017]\]. The microbiota of the anterior midgut of the BSF contained the greatest microbial diversity, which gradually decreased distally; however, in contrast, bacterial load increased. The native gut microbiota (i.e., indigenous) of a number of insects has been determined to provide immunity against select pathogens \[[@pone.0225873.ref018],[@pone.0225873.ref019],[@pone.0225873.ref020]\]. For example, the microbial community of the red flour beetle *Tribolium castaneum*, Herbst, (Coleoptera:Tenebrionidae) offers protection against *Bacillus thuringiensis* bv *tenebrionis* \[[@pone.0225873.ref021]\]. Experiments on silkworm *Bombyxmori*, L., (Lepidoptera: Bombycidae) demonstrated that lactic acid bacteria in the gut enhance host resistance against *Pseudomonas aeruginosa*. Despite the involvement of native gut microbiota in combating infections, the manner by which the immune system of BSFL regulates gut microbiota homeostasis to suppress zoonotic pathogens remains unknown.

In this study, we examined the antimicrobial activity of immune genes dual oxidase (*BsfDuox*) and TLR 3 (*BsfTLR3*) in BSFL, which represent two classic immune pathways. We explored the, (1) reduction in pathogen loads in pig manure by BSFL, (2) expression profile of immune genes *BsfDuox* and *BsfTLR3* in BSFL, (3) expression profile of immune genes after oral pathogenic bacterial challenge, (4) whether suppression of zoonotic pathogens by BSFL is reduced after *BsfDuox-TLR3* RNA interference, and (5) the dynamic change in intestinal bacterial community after RNAi of *Duox-TLR3* genes and their relationship with the suppression of zoonotic pathogens.

Material and methods {#sec002}
====================

Rearing and dissection of *H*. *illucens* L. {#sec003}
--------------------------------------------

The colony of BSF (Wuhan strain) used in this study was located at the State Key Laboratory of Agricultural Microbiology of HZAU. BSFL were reared for 10 days at 27°C and 70%-80% relative humidity on an artificially sterilized feed (75 g of wheat bran, 75 g of corn flour, and 350 g of water mixed and then autoclaved at 121°C for 15 min). Third instars were surface-sterilized prior to use. After a 70% ethanol wash for one minute, the BSFL is washed three times in sterile water for one minute. Approximately 60 larvae from each experiment were dissected in sterile distilled water with a sterilized tweezers under a stereo microscope \[[@pone.0225873.ref022]\]. The dissected guts were transferred to a 2 ml sterile grind tube containing PBS(0.01 M, 1ml) and ground guts into homogenate. The homogenate was used for the different experiments.

Zoonotic pathogenic bacteria assay in pig manure conversion {#sec004}
-----------------------------------------------------------

One hundred of surface-sterilized BSFL at 8--10 days old were placed into 100 g of fresh pig manure collected from a facility located near the university. In addition, the control group consisted of 100g pig manure. After interfering with the genes of *Duox* and *TLR3*, the transformation experiments were also carried out. 10^5^ CFU/g *Salmonella* spp. and 10^6^ CFU/g *S*. *aureus*, as well as 100 *Duox-TLR3* RNAi-injected larvae, were added to the 100 g sterilized feed. All treatments were replicated three times. The method for detecting targeted zoonotic pathogens was based on the National Standards of China GB4789.10--2010, in which *Staphylococcus aureus* was detected in 8 days \[[@pone.0225873.ref023]\]. The methods are described as follows. The selective medium (purchased from Qingdao Hope Bio-technology Co., Ltd) for *S*. *aureus* was prepared by placing 6.3 g of Baird-Parker agar in 95 ml of distilled water, heated to a boil until completely dissolved, autoclaved at 121°C for 15 min, and agitated well after sterilization, thereby preventing agar from depositing at the bottom and solidifying. The medium was then cooled to 50°C, 5 ml of potassium citrate-potassium yolk enrichment solution added, gently agitated, and poured into a plastic plate(diameter:90 mm). To count *S*. *aureus* colonies, we first collected manure samples (5 g) at different times after larval introduction (0, 2, 4, 6, and 8 days). Samples were mixed with 45 ml of sterile physiological saline in a 100 ml sterile glass conical flask and agitated for 16 min at 180 rpm. The sample was stored at room temperature (RT) for 5 min prior to the upper layer be sampled. Each sample was diluted using 0.9% saline solution. For each dilution, 0.1 ml was mixed with the appropriate selective medium and plated. Pathogen counts were determined using selective plates, following incubation of plates at 37°C for 48 h. *S*. *aureus* colonies exhibited a diameter of 2--3 mm, gray to black appearance, light-colored edge, turbid zone, and transparent ring on the outer layer. The mean *S*. *aureus* count of three plates was expressed as logCFU/g.

Sample processing to perform the counts was performed in the same way for *Salmonella* spp. as for *S*. *aureus*. Briefly, triplicate plating of the previous samples described was used following GB 4789.4--2016 \[[@pone.0225873.ref024]\] (Standards Press of China, 2010). The medium used for isolating *Salmonella* spp. growth(Qingdao Hope Bio-technology Co.,Ltd) was prepared by adding 5 g of bismuth sulfite agar to 100 ml of distilled water that was then stirred and boiled for 1 min, cooled to 50°C-55°C, plated, and used the next day. The mean *Salmonella* spp. (CFU/g) of triplicate plates was determined as logCFU/g(Standards Press of China, 2016).

Total RNA isolation and cDNA synthesis {#sec005}
--------------------------------------

Total RNA was isolated from black soldier fly at different developmental stages, including eggs, first-fourth instars, adults after mating (13--15 days after eclosion) using RNA extract reagent kit (Invitrogen, Thermofisher, USA).Taking 100 steriled (90% alcohol wash for 1 minute and distilled water wash for 1 minute) eggs in the egg-laying carton of the adult BSF and grind them in trizol extraction kit to extract RNA(Invitrogen, Thermofisher, USA) according to the manufacturer instructions. In addition, total RNA was isolated from different organs and tissues such as gut and the whole body. In addition, total RNA was isolated from RNAi-*Duox-TLR3* and RNAi-*egfp* groups. The experiments were performed three times. RNA quality was analyzed by NanoDrop 2000 spectrophotometry (ThermoFisher Scientific Inc., Waltham, MA, USA) at 260 nm. 1 μg of total RNA was reversely transcribed into first-strand cDNA by using Hiscipt 1st stand cDNA synthesis kit (Nanjing Vazyme Biotechnology Co., Ltd, Nanjing, China).

Sequence analysis of full-length *BsfDuox* and *BsfTLR3* {#sec006}
--------------------------------------------------------

The genome of BSF was sequenced and assembled. The genome size of BSF was 1.1 Gb, which is relatively large among the Diptera that has been sequenced \[[@pone.0225873.ref025]\]. The *BsfDuox* and *BsfTLR3* genes were searched in the BSF genome database by using the Duox protein sequence and TLR3 protein sequence of the fruit fly. The highest similarity sequence of protein was the protein sequence of Duox and TLR3 of BSF. Specific primers for *BsfDuox* and *BsfTLR3* were designed on the basis of the fragment sequence searched from BSF genome database using Premier5.0 software. The transmembrane domains in *BsfDuox* and *BsfTLR3* were identified using TMHMM online software (<http://www.cbs.dtu.dk/services/TMHMM-2.0/>) and the structural domains of *BsfDuox* and *BsfTLR3* were predicted using the simple modular architectural research tool (SMART, version 7.0, <http://smart.embl-heidelberg.de/>).

Microbial oral infection {#sec007}
------------------------

Third-instar fed an artificial diet supplement with 5% sucrose solution containing concentrated microbe solution (1 × 10^8^ colony-forming units (CFUs) per ml).The microorganisms used in this study were zoonotic pathogens, *S*. *aureus* and *Salmonella* spp. from the State Key Laboratory of Agricultural Microbiology of HZAU. Bacteria used for oral infection were grown in lysogeny broth medium at 28°C and 180 rpm. Exponential microbial culture (OD~600~ = 1.0) was used for all the experiments as previously described \[[@pone.0225873.ref026]\] and centrifuged for 15 s (8,000 g), then adjusted to the final concentration with aseptic distilled water. The resulting bacterial counts in each sample were adjusted to approximately 1×10^8^ CFU/ml by aseptic distilled water. We did a preliminary experiment initially to establish appropriate methods. The sample of different dilutions were applied on LB plates after overnight culture at 37°C, the number of bacteria on the plate was counted to calculate the number of acquired bacteria by per larvae, then measure the turbidimetric OD value of the sample by spectrophotometer, it will take several days. For formal experiment, the bacterial turbidimetric OD value of all the sample was measured by spectrophotometer refer to the turbidimetric OD value of the preliminary experiments results.

Third-instars (8 days old) were fed a 1 ml solution containing concentrated microbes(approximately 1×10^8^ CFU/ml). The larvae fed with a 5% sucrose diet only served as the control. For the analyses of *BsfDuox* and *BsfTLR3* gene expression and ROS level changes after oral infection, the gut samples of different treatments were collected at different times post-oral infection(POI).

Real-time quantitative PCR (qRT-PCR) analysis {#sec008}
---------------------------------------------

In all cases of gene expression analysis, three independent cohorts of third-instar BSFL were collected for RNA extraction and cDNA synthesis. In the present work, genes, such as *Duox*, *TLR3*, *egfp*, *drosal*, *cecropin*, *ubiquitin*, *dif* and *stomoxyn* were investigated for their expression level at the third-instar stage. The primers for these gene was shown in [S1 Table](#pone.0225873.s008){ref-type="supplementary-material"}. qRT-PCR was performed using a Bio-Rad CFX system (Bio-Rad, Hercules, CA, USA) with a 384-well plate. Each PCR mixture consisted of 7.8 μl of SYBR Green Mix (Hiscipt 1st stand cDNA synthesis kit, Nanjing Vazyme Biotechnology Co., Ltd, Nanjing, China), 10 nM of each primer, and 2 μl of cDNA (diluted 1:10). The amplification program consisted of pre-incubation at 95°C for 3 min, followed by 39 cycles of denaturation at 95°C for 20 s, annealing at 56°C for 20 s, and extension at 72°C for 20 s. After the fluorescence quantitative PCR was over, the dissolution curve was analyzed to ensure specific amplification followed by 40 cycles started at 65°C for 10 s with a 0.5°C increase for 5 s each cycle until 95°C. Real-time fluorescence quantitative PCR results were measured by 2^-ΔΔCt^ method as described previously \[[@pone.0225873.ref027]\]. All the samples were analyzed in triplicate, and the levels of the detected mRNA determined by cycling threshold analysis were normalized using β-actin as the control, The target gene expression is presented as the relative expression levels after normalization. The loads of total bacteria were quantified by qRT-PCR using 16S rRNA gene-specific primers (F `5’-ACTCCTACGGGAGGCAGCAG` and R `5’-ATTACCGCGGCTGCTGG`) \[[@pone.0225873.ref028]\] and normalized by using β-actin as the control via a previously described method \[[@pone.0225873.ref029]\]. PCR mixture consisted of 7.8 μl of SYBR Green Mix (Hiscipt 1st stand cDNA synthesis kit, Nanjing Vazyme Biotechnology Co., Ltd, Nanjing, China), 10 nM of each primer, and 2 μl of cDNA (diluted 1:10). The amplification program was the same as described above. All the samples were analyzed using ANOVA method.

Measurement of intestinal ROS {#sec009}
-----------------------------

The intestine of individual third-instar larvae was hand-dissected in PBS(0.01 M, 1ml). Three independent cohorts of three intestines were used for each measurement. The dissected intestines were ground with PBS solution(0.01 M, 1ml) in the grinder. The quantification of ROS was completed according to the corresponding kit instructions provided by the Institute of Nanjing Jiancheng Bioengineering. In brief, dissected intestines were weighed using a weighing meter, then was added nine times volume of 0.9% saline, centrifuged the sample at 5,000 g for 5 min, the supernatant was further used for the colorimetric quantitative determination of diffused ROS. The absorbance values of each tube were measured under 405 nm by using UV756 (756 spectrophotometer, Shanghai Opal Instrument Co., Ltd.). The spectrophotometer was preheat for 30 min or more and adjust the wavelength to 405 nm, using distilled water adjust to zero. We detected ROS after a 30-min incubation of the diluted supernatant with the working solution I, II, III, IV(Volume ratio:10:0:1:2:10). Sample was added working solutionI, II, III and centrifugated (4000 g, 25°C, 10 min) then discarded the supernatant. Adding the working solution IV to solve the precipitation and take 200 μl to the colorimetric dish to determine the absorbance value .ΔOD = determined OD-referenced OD. The protein concentration of each tube was determined by NanoDrop2000 (ThermoFisher Scientific Inc., Waltham, MA, USA). The ROS value of each tube was calculated using the following formula: ROS concentration = (measured OD value−blank OD value) × 163 / (Standard OD value−blank OD value) × sample protein concentration.

Double-stranded RNA (dsRNA) synthesis and delivery by injection {#sec010}
---------------------------------------------------------------

The *BsfDuox* and *BsfTLR3* sequence fragments were amplified with PCR with premier 5.0 to design of specific primers conjugated with the T7 RNA polymerase promoter. The primer pairs used in dsRNA synthesis are shown in [S1 Table](#pone.0225873.s008){ref-type="supplementary-material"}.1 μg PCR product was used as the template for dsRNA synthesis utilizing the T7 Ribomax Express RNAi System (Promega, Madison, WI, USA). The dsRNA was isopropanol-precipitated overnight, resuspended in RNase-free H~2~O, and quantified at 260 nm by using a NanoDrop 2000 spectrophotometer (ThermoFisher Scientific Inc., Waltham, MA, USA) before microinjection. The quality and integrity of dsRNA were determined by agarose gel electrophoresis. The injection condition was set to P~i~ of 300 hpa and T~i~ of 0.3 s using an Eppendorf micromanipulation system (Microinjector for cell biology, FemtoJet 5247, Hamburg, Germany). Gene silencing experiments of *Duox-TLR3* RNAi and *egfp* RNAi larvae were performed by injecting 1 μl of 2 μg/μl *dsDuox*-RNA and *dsTLR3*-RNA solution as well as *dsegfp*-RNA into the abdomen of each larva.

Isolation of bacterial DNA from the gut and high-throughput sequencing {#sec011}
----------------------------------------------------------------------

Total bacterial genomic DNA samples from the intestines of 21 individuals were extracted using Fast DNASPIN extraction kits (MP Biomedicals, Santa Ana, CA, USA) according to the manufacturer's instructions and stored at −20°C prior to further analysis. The quantity and quality of extracted DNA were measured using a NanoDrop ND-1000 spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA) and agarose gel electrophoresis, respectively. PCR amplification of the bacterial 16S rDNA genes to assess the microbial diversity of the BSFL at the V3--V4 regions was performed using 338F (`5’-ACTCCTACGGGAGGCAGCA-3’`) and 806R (`5’-GGACTACHVGGGTWTCTAAT-3’`). These primers were designed to contain a 7 nt barcode sequence for multiple samples. PCR was performed in a total reaction volume of 25 μl. The PCR conditions were as follows: initial denaturation at 95°C for 5 min; 30 cycles of 94°C for 20 s, 58°C for 30 s, and 72°C for 30 s; and a final extension at 72°C for 2.5 min. PCR amplicons were purified with Agencourt AMPure beads (Beckman Coulter, Indianapolis, IN, USA) and quantified using the PicoGreen dsDNA assay kit (Invitrogen, Carlsbad, CA, USA). Purified PCR product libraries were quantified by Qubit dsDNA HS Assay Kit, amplicons were pooled in equal amounts, and pair-end 2 × 300 bp sequencing was performed using the Illumina Miseq PE2500 platform with MiSeq Reagent Kit version 3 (Shanghai Personal Biotechnology Co., Ltd., Shanghai, China). A total of 21 gut samples were subjected to high-throughput sequencing, including three gut samples of 8- to 10-day-old larvae with no treatment of RNAi and 18 gut samples of the *egfp* RNAi- and *Duox*-*TLR3* RNAi-treated larvae from 4, 8, and 12 days post-RNAi (DPR).

The raw data have been upload to NCBI under BioprojectID PRJNA600829 and SRA under SRP247530. Data analysis was conducted by the bioinformatics software called Quantitative Insights into Microbial Ecology (QIIME, v. 1.8.0) \[[@pone.0225873.ref030]\]. We get clean sequence reads by removing of the primer sequence, truncation of sequence reads less than an average quality of 20 over a 30 bp sliding window based on the Phred algorithm, and removal of sequences that had a length of \<150 bp, as well as sequences that contained mononucleotide repeats of \>8 bp \[[@pone.0225873.ref031]\]. These strict criteria resulted in nearly 94% of the reads being retained.

FLASH (Fast Length Adjustment of Short reads)was used to extend the length of short reads by overlapping paired-end reads for genome assemblies \[[@pone.0225873.ref032]\]. First, we sorted exactly the same sequence of clean reads according to their abundance and filtered out the singletons and used Usearch tool to cluster under 0.97 similarity. After chimera detection the remaining high-quality sequences were clustered into operational taxonomic units(OTUs) by UCLUST \[[@pone.0225873.ref033]\]. Selecting the highest abundance sequence from each OTU Library as the representative sequence by using default parameters. OTU taxonomic classification was conducted by BLAST search of the representative sequences set against the 16S database of known species (RDP, [http://rdp.cme.msu.edu](http://rdp.cme.msu.edu/)) \[[@pone.0225873.ref034]\] using the best hit \[[@pone.0225873.ref035]\]. Reads that did not match a reference sequence at 97% identity were discarded. Bioinformatics and sequence data analyses were mainly performed using QIIME and R packages (version 3.2.0). Using QIIME software calculates the alpha diversity index of a sample including richness and diversity indices (observed species \[Sobs\], Chao, abundance-based coverage estimator \[ACE\], and Shannon) and dissimilarity matrices (Bray--Curtis and weighted UniFrac) \[[@pone.0225873.ref036],[@pone.0225873.ref037]\].

Statistical analysis {#sec012}
--------------------

Results are shown as the average ± SEM of three independent biological samples. Each experiment was performed three times. Comparison between the two independent samples were performed with student\'s t-test. Multiple comparisons were conducted by one-way ANOVA (GraphPad Software, La Jolla, CA, USA). Significant level was set at p \< 0.05. The graphs were also made using GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA).

Results {#sec013}
=======

BSFL significantly inhibited pathogenic bacteria in the conversion of pig manure {#sec014}
--------------------------------------------------------------------------------

We investigated the inhibitory action of BSFL in the natural conversion of pig manure. BSFL significantly reduced *S*. *aureus* and *Salmonella* spp. counts in pig manure from day 2 through day 8. The number of *S*. *aureus* and *Salmonella* spp. was 5.47 log CFU/g and 6.71 log CFU/g on day zero, respectively. On the eighth day after conversion, the number of *S*. *aureus* and *Salmonella* spp. reduced to 2.31 log CFU/g and 1 log CFU/g, respectively. BSFL exhibited the greatest success in reducing *S*. *aureus* from days 2 until days 8. The inhibition rate increased significantly from the fourth to the sixth day, and reached the peak on the eighth day while the number of *S*. *aureus* in pig manure decreased to the lowest. The inhibition rate of the BSFL to *Salmonella* spp. reached the highest from the second day to the fourth day, after which the inhibition rate dropped to 0 until the eighth day ([Fig 1](#pone.0225873.g001){ref-type="fig"}).

![Mean *Staphylococcus aureus* (A) and *Salmonella* spp. (B) log CFU/g (mean ± SEM) during 8 days conversion in pig manure with 8-d-old black soldier fly larvae (control) and stored at 27°C, 60%-70%RH, and a photoperiod of 16:8 (L:D) h in a growth chamber.](pone.0225873.g001){#pone.0225873.g001}

Attenuation of bacteriostasis after *Duox-TLR3* RNAi {#sec015}
----------------------------------------------------

After RNAi of *Duox-TLR3* in BSFL, we simulated the experiment of pig manure conversion by BSFL using the sterilized feed. By compared with pig manure, the use of sterilized feed(add only *S*.*aureus* and *Salmonella* spp.) can reduce the interference of other pathogenic bacteria(see [materials and methods](#sec002){ref-type="sec"}). On day 0 and 8^th^ of conversion, the *S*. *aureus* count was 6.43 log CFU/g and 6.73 log CFU/g, respectively, and the *Salmonella* spp. count was 5.66 log CFU/g and 5.74 log CFU/g, respectively. In the *Duox-TLR3* RNAi group, the BSFL were also able to inhibit *S*.*aureus* on day 0 to day 2 of conversion. The inhibitory effect on *S*. *aureus* was reduced from 2^th^ day to 8^th^ day. Meanwhile, the BSFL were also able to inhibit *Salmonella* spp from day 0 to day 4 of conversion. The inhibitory effect on *Salmonella* spp. was reduced from the 4^th^ to 8^th^ day. Thus, the BSFL induced a diminished effect on pathogen inhibition in *Duox-TLR3* RNAi-injected larvae compared with the natural pig manure transformation conditions ([Fig 2](#pone.0225873.g002){ref-type="fig"}).

![Mean *Staphylococcus aureus* (A) and *Salmonella* spp. (B). log CFU/g± SD during 8 days conversion in *Duox-TLR3* RNAi larvae group with (control) 8-d-old black soldier fly larvae and stored at 27°C, 60--70%RH, and a photoperiod of 16:8 (L:D) h in a growth chamber.](pone.0225873.g002){#pone.0225873.g002}

Sequence analysis and expression profiles of *BsfDuox* and *BsfTLR3* {#sec016}
--------------------------------------------------------------------

We searched the *BsfDuox* and *BsfTLR3* cDNA from the genome database of the BSF. *BsfDuox* was 4.2 kb and encoded 1540 amino acids ([S1 Fig](#pone.0225873.s001){ref-type="supplementary-material"}), whereas *BsfTLR3* was 1.134 kb and encoded 378 amino acids ([S2 Fig](#pone.0225873.s002){ref-type="supplementary-material"}). Structural analyses demonstrated that *BsfDuox* consists of FAD-binding and NAD-binding domains and ferric-reduct domain typical of all members of electronic delivery system responsible for H~2~O~2~ generation, as well as extracellular peroxidase homology domain (PHD). The PHD shows myeloperoxidase activity, thereby enabling the conversion of H~2~O~2~ to HOCl in the presence of chloride ion. PHD of Duox is vital for the host immune defense system ([S3 Fig](#pone.0225873.s003){ref-type="supplementary-material"}). BSFL have one *TLR3* gene, which primes the immune response. Structural analyses demonstrated that *TLR3* had three Leucine-rich repeat domains and was responsible for the protein binding and cell signaling functions ([S4 Fig](#pone.0225873.s004){ref-type="supplementary-material"}). The structure of *BsfDuox* and *BsfTLR3* was similar with the previously reported *Duox* and *TLR3* of *B*. *dorsali*s, suggesting that they may have the same function.

The *BsfDuox* gene was highly expressed in the egg, first, second, and fourth instar as well as adult stages, but it was weakly expressed in the third-instar larval stage ([S5A Fig](#pone.0225873.s005){ref-type="supplementary-material"}). The *BsfTLR3* gene was highly expressed in the egg, first, second, third, and fourth instar stages, but it was weakly expressed in the adult stage ([S5B Fig](#pone.0225873.s005){ref-type="supplementary-material"}). We speculated that the two genes have different expression level to meet their different functions at different stages of BSF development.

*BsfDuox* and *BsfTLR3* genes were induced upon infection {#sec017}
---------------------------------------------------------

To investigate the role of *BsfDuox* and *BsfTLR3* in the immune system response, we detected *BsfDuox* and *BsfTLR3* gene expression in the gut upon oral infection with *S*. *aureus* and *Salmonella* spp. More specifically, *S*. *aureus* induced a 4.05-times in *BsfDuox* gene expression with a peak at 12 h POI ([Fig 3A](#pone.0225873.g003){ref-type="fig"}). Consistent with this, ROS level was increased at 12 h ([Fig 3B](#pone.0225873.g003){ref-type="fig"}). *Salmonella* spp. did not activate the *Duox* gene at any point significantly. *Salmonella* spp. and *S*. *aureus* differently induce the expression of *Duox* gene. Thus, *BsfDuox* gene expression may be regulated by factors secreted by *S*. *aureus*. To date, uracil secreted by bacteria is the only bacterial ligand \[[@pone.0225873.ref038]\] that can activate *Duox* activity. Our results showed that *S*. *aureus* induced a 1.76-fold increase in *BsfTLR3* gene expression at 1 h POI, whereas *Salmonella* spp. induced a 1.75-fold increase in *BsfTLR3* gene expression at 4 h POI. Thus, gram-positive and gram-negative bacteria could induce *TLR3* gene expression ([Fig 3C](#pone.0225873.g003){ref-type="fig"}). This study also showed that oral *S*. *aureus* infection to BSFL could induce the expression of the toll-like receptor pathway nucleic acid transcription factors *Dif* and *Dorsal* to mediate antibacterial activity ([Fig 4](#pone.0225873.g004){ref-type="fig"}).

![The response of the *BsfDuox* gene and *BsfTLR3* gene in the gut during oral infection.\
(A) Expression levels of *BsfDuox* at different time points in whole guts (without Malpighian tubules) after oral infection with *S*. *aureus* and *Salmonella* spp. (B) Expression levels of *BsfTLR3* at different time points in whole guts (without Malpighian tubules) after oral infection with *S*. *aureus* and *Salmonella* spp. (C) The total intestinal ROS levels were quantified with flies at different time points after oral infection. Data are representative of three independent experiments (mean ± SEM). Statistical comparison was based on Student's t--test (\**p*\< 0.05,\*\**p*\< 0.01, \*\*\**p*\< 0.001). Different letters indicate a significant difference in *BsfD*uox expression and *BsfTLR3* expression and ROS levels among the oral infection with *Salmonella* spp. or *S*. *aureus*.](pone.0225873.g003){#pone.0225873.g003}

![(A) The expression level of *Bsf dorsal*gene at different time points after oral infection of *S*. *aureus* (B) The expression level of *Bsf dif* gene at different time points after oral infection of *S*. *aureus*.Values are the mean ± SEM of three independent experiments. Statistical comparison was based on Student's t--test(\**p*\< 0.05,\*\**p*\< 0.01, \*\*\**p*\< 0.001 with Student'S t--test).](pone.0225873.g004){#pone.0225873.g004}

Sequential difference between the intestinal *Duox-ROS/Toll* signaling pathway after zoonotic pathogen challenge {#sec018}
----------------------------------------------------------------------------------------------------------------

We studied the temporal differentiation of the immune response of Duox-ROS immunity and Toll signaling pathway by feeding the zoonotic pathogen *S*. *aureus* to larvae. Infected by zoonotic pathogens could induce the immune response of the Duox-ROS system and Toll signaling pathway in a short time.

*S*. *aureus* induced a 2.65-fold increase in ROS in the host intestine after 4 h ([Fig 3B](#pone.0225873.g003){ref-type="fig"}) but a two-fold increase in *Bsfdorsal* gene in the Toll signaling pathways after 8 h ([Fig 4A](#pone.0225873.g004){ref-type="fig"}). The effector gene *Dif* increased by six-fold after 12 h POI compared with the control ([Fig 4B](#pone.0225873.g004){ref-type="fig"}). Thus, the immune response of the Duox-ROS system to zoonotic pathogen challenge was earlier than that of the Toll pathway.

*BsfDuox-TLR3* regulated gut bacterial density {#sec019}
----------------------------------------------

On the basis of the above results ([Fig 3](#pone.0225873.g003){ref-type="fig"}), we concluded that the *BsfDuox* and *BsfTLR3* genes were activated differentially with zoonotic pathogens. Immune genes *Duox* and *TLR3* are expressed to control gut microbiota. It was not H~2~O~2~ the only measurable bioactive compound controlling the microbial load. Subsequently, we tested the change in composition of different intestinal symbionts that reacted to the silencing of the *Duox-TLR3* gene by injecting larvae with *ds-Duox-TLR3*. The level of *BsfDuox* gene transcript was inhibited at 4--8 days, *BsfDuox* gene expression varied from 85% to 88% compared with the *egfp* RNAi control ([Fig 5A](#pone.0225873.g005){ref-type="fig"}). However, *BsfDuox* expression increased in *Duox-TLR3* RNAi-treated larvae at 10 days and then returned to the basal expression level at 12 days. The level of ROS followed the same pattern with a decrease of 48%-57% as compared with the *egfp* RNAi control at 4--8 days and with an increase of 21% at 10--12 days ([Fig 5B](#pone.0225873.g005){ref-type="fig"}). The level of *BsfTLR3* expression was inhibited at 6--10 days, *BsfTLR3* gene expression varied from 77% to 88% compared with the *egfp* RNAi control. *BsfTLR3* gene expression was 4.48 times higher in *Duox-TLR3* RNAi-treated larvae at 12 days than in the *egfp* RNAi control ([Fig 5C](#pone.0225873.g005){ref-type="fig"}). Interestingly, the analysis of the overall bacterial density by qRT-PCR showed that *Duox-TLR3* RNAi larvae had more bacteria at 4--10 days compared with the control. The bacteria load returned to the wild-type level at 12 days ([Fig 5D](#pone.0225873.g005){ref-type="fig"}).

![Interference effects of RNAi of the *BsfDuox*-*TLR3* gene.\
(A) The expression level of the *BsfDuox* gene at different time points after injecting ds-*D*uox-*TLR3* and ds-*egfp*. (B) The expression level of the Bsf*TLR3* gene at different time points after injecting ds-*D*uox-*TLR3* and ds-*egfp*. (C) The total intestinal ROS levels at different time points. (D) The total gut bacterial load at different time points. Data are representative of three independent experiments (mean ± SEM). Statistical comparison was based on Student's t--test (\**p*\<0.05, \*\**p*\<0.01,\*\*\**p*\< 0.001).](pone.0225873.g005){#pone.0225873.g005}

BSFL feeding on a diet containing high bacterial loads could induce the production of an expanded spectrum of antimicrobial peptides (AMPs) \[[@pone.0225873.ref039]\]. However, the expression of AMP was also down-regulated after interfering with two immune genes. The AMP level of cecropin expression in *Duox-TLR3* RNAi larvae decreased by 26.14--36 times compared with that in the control at 8 and 10 days ([Fig 6A](#pone.0225873.g006){ref-type="fig"}). The AMP level of ubiquitin expression in *Duox-TLR3* RNAi larvae decreased by 8.71--41.55 times compared with that in the control at 6, 8, and 10 days ([Fig 6B](#pone.0225873.g006){ref-type="fig"}). The AMP level of stomoxyn ZH1 expression in *Duox-TLR3* RNAi larvae decreased by 7.93 times compared with that in the control at 10 days ([Fig 6C](#pone.0225873.g006){ref-type="fig"}). The results of 16s DNA sequencing of the intestinal tract of BSF showed that the beneficial symbiont bacteria in *Duox-TLR3* RNAi-injected larvae were 3.4% lower than that in *egfp* RNAi-injected larvae \[[@pone.0225873.ref040]\] ([Fig 7A](#pone.0225873.g007){ref-type="fig"}), whereas the pathogenic bacteria in *Duox-TLR3* RNAi larvae was less than the control group at 4 days while increased by 44.8% compared with that in *egfp* RNAi larvae at 8 days post-RNAi (DPR; [Fig 7B](#pone.0225873.g007){ref-type="fig"}). However, these differences were not statistically significant. The depletion of these two immune genes in BSFL reduced AMP and ROS production, leading to the decrease in symbiont bacteria and increase in pathogenic bacteria.

![The expression level of antimicrobial peptide genes (A) *Bsf cecropin*, (B) *Bsf ubiquitin*, (C) *Bsf stomoxynZH1*, in black soldier fly larvae following the *Duox* and *TLR3* RNA interference. Data are representative of three independent experiments (mean ± SEM). Statistical comparison was based on Student's t--test (\**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\< 0.001).](pone.0225873.g006){#pone.0225873.g006}

![(A) The beneficial symbiont in *Duox-TLR3* RNAi larvae and *egfp* RNAi larvae at 4,8,12 days post dsRNA interfence (B) The pathogenic bacteria in *Duox-TLR3* RNAi and *egfp* RNAi larvae at 4, 8, 12 days post dsRNA interfence. Values are the mean ± SEM of three independent experiments.](pone.0225873.g007){#pone.0225873.g007}

The interference of *BsfDuox-TLR3* gene reduced the ROS and AMP expression levels, resulting in an increase in the number of intestinal bacteria. We attributed the low *BsfDuox* and *BsfTLR3* gene expression levels and ROS levels observed at 4--8 days to the increase in bacteria at a time when RNAi was effective. Low levels of gene expression after interference led to an increase in the total number of bacteria, as well as an increase in the number of pathogenic bacteria, which can stimulate gene expression to return to normal after interference that is the activities that take the observed number of days to recover normal activity. Conversely, high levels of *BsfDuox* gene expression and ROS at 10 days resulted from the decrease in bacteria at a time when RNAi was ineffective. Thus, the larval innate immune genes *BsfDuox* and *BsfTLR3* were in regulating the homeostasis of the gut bacterial and in controlling the bacterial load in the midgut, and exposure to increased pathogens resulted in the increased production of some of these anti-pathogenic factors.

*BsfDuox-TLR3* regulated the intestinal bacterial community homeostasis {#sec020}
-----------------------------------------------------------------------

*BsfDuox* and *BsfTLR3* regulated bacterial community density but whether *BsfDuox* and *BsfTLR3* affect the gut bacterial community composition remains unknown. The bacterial composition in *egfp* RNAi-treated and *Duox-TLR3* RNAi-treated larvae was investigated by MiSeq Illumina high-throughput sequencing. The rarefaction curves moved toward saturation representing the bacterial community well ([S6A Fig](#pone.0225873.s006){ref-type="supplementary-material"}). Rank abundance curve showed a rich species composition ([S6B Fig](#pone.0225873.s006){ref-type="supplementary-material"}). Overall, five bacterial phyla were detected in BSF samples, namely, Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, and TM7, which composed 63.2%, 18.7%, 16.4%, 1.29%, and 0.41% of the bacterial communities in the gut, respectively. Differences between the bacterial community of *egfp* RNAi and *Duox-TLR3* RNAi samples were calculated using the UniFrac metrics, which measures phylogenetic dissimilarities between microbial communities \[[@pone.0225873.ref041]\]. Genus- and species-level profiling histograms and principal coordinate analyses based on weighted UniFrac demonstrated great variation in the composition of the gut microbial community upon *Duox-TLR3* RNAi and *egfp* RNAi treatment, especially on days 4 and 8 post-dsRNA injection ([Fig 8A](#pone.0225873.g008){ref-type="fig"}). Principal coordinate analysis showed separation of *Duox-TLR3* RNAi- and *egfp* RNAi-treated samples along the major component 1(pc1) and major component 2 (pc2) axes, which explained 44.01% and 21.08% of data variation ([S7 Fig](#pone.0225873.s007){ref-type="supplementary-material"}), respectively. The analysis of the control *egfp* RNAi samples further confirmed that the intestinal bacterial composition was rich in diversity, and the major genus members of the gut community of BSF were *Providencia*, *Morganella*, *Wohlfahrtiimonas*, and *Dysgonomonas*, whereas the minor members were *Lactococcus*, *Comamonas*, *Pseudomonadaceae*, and *Leucobacter*([Fig 8A](#pone.0225873.g008){ref-type="fig"}). At 4^th^ day, a decrease of 12% and 14.8% abundance of *Providencia* and *Dysgonomonas* in *Duox-TLR3* RNAi larvae compared with that of control, respectively. However, the relative abundance of others indigenous bacteria increased by 1.17 times in the *Duox-TLR3* RNAi larvae than in the control larvae ([Fig 8B](#pone.0225873.g008){ref-type="fig"}). Bacterium *Lactococcus* with low relative abundance increased to detectable levels in the *Duox-TLR3* RNAi larvae compared with that in the control larvae, which in *egfp* group could not reach the minimum level for detection because of their relatively low abundance.The minor group bacterium *Leucobacter* also has certain increase in *Duox-TLR3* RNAi group.([Fig 8C](#pone.0225873.g008){ref-type="fig"}). On the 8^th^ day after dsRNA injection, the relative percentage of *Leucobacter* bacteria in the *Duox-TLR3* RNAi was still significantly higher than that of the control group, The relative proportion of *Lactococcus* bacteria was similar to that of 4^th^ day after dsRNA injection. However, on the 12^th^ day after dsRNA injection, the relative proportion of bacteria in the *Duox-TLR3* RNAi group recovered to the same level as that in the *egfp* control group except to the *Comamonas* bacteria in the *egfp* RNAi group higher than those in the *Duox-TLR3* RNAi group. Thus, the larvae with reduced *BsfDuox* and *BsfTLR3* gene expression displayed a significant difference in bacterial community composition, possibly because of variations in the resistance of bacteria to ROS killing activity. At 8^th^ day, the abundance of *Pseudomonadaceae*, a family of bacteria with low relative abundance in *Duox-TLR3* RNAi larvae increased significantly by two fold compared with that in the controls. The relative abundance of *Comamonas* at 8^th^ day was similar with that at 4^th^ day in *Duox-TLR3* RNAi larvae and was higher than that of *egfp* RNAi group([Fig 8E](#pone.0225873.g008){ref-type="fig"}), which may be due to the reduced ROS and AMP production levels. After *ds-Duox-TLR3* injection at 12^th^ day, disordered intestinal bacterial communities stimulated the expression of the *BsfDuox* gene and the production of ROS to suppress non-symbionts. Finally, bacteria taxa composition in *Duox-TLR3* RNAi-treated larvae at 12^th^ day return to wild-type, excluding *Dysgonomonas* and *Morganella*, which remained high in *Duox-TLR3* RNAi-treated larvae. Therefore, the *Duox-TLR3* gene had a pivotal role in regulating the structure of the bacterial community in BSFL ([Fig 8F](#pone.0225873.g008){ref-type="fig"}). In the present study, the gene interference of *Duox-TLR3* resulted in a decrease in the number of beneficial symbiotic bacteria *Providencia* and *Dysgonomonas* and an increase in the number of conditional pathogenic bacteria *Pseudomonadaceae*, leading to reduced resistance to pathogenic bacteria in the environment.

![*BsfDuox-TLR3*gene regulates the composition and structure of gut bacterial community.\
(A) Taxonomic breakdown at the genus level grouped by ds-*egfp* and ds-*Duox-TLR3* treatments. (B-G) Relative abundance of different bacterial taxa after injecting ds-*Duox-TLR3*and ds-*egfp* at 4, 8 and 12 Day. Data are representative of three independent experiments (mean+s.e.m.). Statistical comparison was based on Student's t--test (\**p*\<0.05). ND, not detected.](pone.0225873.g008){#pone.0225873.g008}

With the use of PICRUST, different RNAi treatments associated with functional potentials was predicted. The intestinal microbiota of *Duox-TLR3* RNAi-treated larvae was more enriched with genes involved in replication, repair, infectious diseases, carbohydrate metabolism, and amino acid metabolism but less enriched with genes involved in the biosynthesis of other secondary metabolism and enzyme family compared with that of *egfp* RNAi-treated larvae ([Fig 9A and 9B](#pone.0225873.g009){ref-type="fig"}).

![All of the predicted KEGG metabolic pathways are shown at the second hierarchical level and grouped by major functional categories.\
(A) KEGG_level2: Genetic information processing. (B) KEGG_level2: Matabolism.](pone.0225873.g009){#pone.0225873.g009}

Microbial community richness was altered by *BsfDuox-TLR3* RNAi {#sec021}
---------------------------------------------------------------

The effect of *Duox*-*TLR3* RNAi on microbial diversity was investigated by a standardized approach that evaluated community richness. At 4^th^ day. the Sobs (1192.3 ± 165.7), Chao(1598.9 ± 128.9), ACE(1628.1 ± 145.6), and Shannon(7.1 ± 0.3) indices of the intestinal microorganisms in *Duox-TLR3* RNAi larvae were the same as the Sobs(1351.3 ± 164.7), Chao(1452.8 ± 223.5), ACE(1488.4 ± 202.1), and Shannon(6.8 ± 1.0) indices in the control larvae([Fig 10A](#pone.0225873.g010){ref-type="fig"}). Meanwhile, the richness metrics of Chao and ACE in *Duox-TLR3* RNAi larvae significantly increased at 8^th^ day. In the control larvae, 1387 Sobs were identified, which was almost identical to those in *Duox-TLR3* RNAi larvae. The Chao, ACE, and Shannon indices increased by 31.17%, 31.6%, and 17.4%, respectively, in the *Duox-TLR3* RNAi larvae compared with those in the control larvae at 8^th^ day ([Fig 10B](#pone.0225873.g010){ref-type="fig"}).

![Effects of RNAi of the *BsfDuox-TLR3*gene on diversity metrics.\
Richness measured as observed operational taxonomic units (OTUs; Sobs), Chao, ACE and Shannon indices of gut bacterial communities from different treatment at three timepoints. (A) 4 DPR. (B) 8 DPR. (C) 12 DPR. Data are representative of three independent experiments (mean ± SEM). Statistical comparison was based on Student's t--test (*p*).](pone.0225873.g010){#pone.0225873.g010}

Finally, no significant difference was noted in the Sobs(1316.0 ± 125.9 vs. 1370.7 ± 151.3), Chao(1464.4 ± 158.8 vs. 1381.3 ± 163.4), ACE(1470.2 ± 142.9 vs. 1398.3 ± 185.1), and Shannon(7.1 ± 0.3 vs. 7.3 ± 0.5) indices between *Duox-TLR3* RNAi and *egfp* RNAi larvae at 12^th^ day([Fig 10C](#pone.0225873.g010){ref-type="fig"}). Thus, *BsfDuox-TLR3* gene silencing by RNAi led to increased bacterial diversity at 8^th^ day compared with the control, possibly because of the low solubility of ROS and AMP.

Discussion {#sec022}
==========

Intestinal microorganisms directly, or indirectly, affect the immunity of intestinal epithelium cells, and thus impacting the internal environment and development of the host. Microbial populations in the gut regulate host immunity by balancing between an efficient immune response to inhibit foreign pathogens from colonizing and proliferating \[[@pone.0225873.ref042]\]. Many immune genes of the host are involved in controlling gut microbes. By feeding BSFL zoonotic pathogenic bacteria it was found that the defense system of *Duox-ROS* plays an important role in the intestinal immune defense of BSFL. The silencing of the BSFL *Duox* gene resulted in a significant decrease in the level of ROS in the intestine, indicating that the ROS in the intestine of BSFL is mediated by *Duox*. The Toll signaling pathway plays an important role in the immune response of the BSFL system, zoonotic pathogenic bacteria can rapidly activate *TLR3*, *Dif*, and *Drosal* genes of toll signaling pathways. The zoonotic pathogens that activate *Duox* and *TLR3* to produce ROS and AMPs that act to restrict the growth and proliferation of invading microorganisms \[[@pone.0225873.ref043], [@pone.0225873.ref044]\]. We determined toll pathway-mutant BSFL lacking AMP expression generally express reduced resistance and suffer lethal effects due to gut infection. By contrast, *Duox-TLR3* inactivation leads to uncontrolled increase of bacteria in the gut as demonstrated in this study. That means the immune system relies mainly on two effector molecules, antimicrobial peptides and ROS, to inhibit the colonization of invasive microbes. With the advent of sequencing technology, many bacterial communities in the gut of various insects have been described. Indigenous bacterial community composition was of medium complexity in *B*. *dorsalis*, which is composed of Porphyromonadaceae, Streptococcaceae, and Sphingobacteriaceae and many unclasssifed bacteria. *BdDuox* silencing led to a decreased abundance of Enterobacteriaceae and Leuconostocaceae in the gut and overgrowth of minor pathobionts \[[@pone.0225873.ref011]\].

Compared with the intestinal bacteria community of *B*. *dorsali*s, that of the BSFL was relatively complex. The dominant symbiotic bacteria, *Providencia*, in the gut of BSF belonged to the family of Enterobacteriaceae. Enterobacteriaceae is a commonly found symbiotic taxon in insects, and specifically belonging to the γ-proteobacteria, a class that includes dominant symbiotic bacteria in many insect lineages \[[@pone.0225873.ref045]\]. Enterobacteriaceae, as dominant commensal bacteria in the intestinal tract of insects, may play an important role in improving host fitness by preventing the colonization of foreign pathogens \[[@pone.0225873.ref046]\] and contribute to nitrogen fixation \[[@pone.0225873.ref047]\]. *Providencia* spp. are gram-negative bacteria that belonged to the Enterobacteriaceae. *Providencia* spp. resist two kinds of antibiotics including colistin and tigecycline, making *Providencia* multidrug-resistant. *Providencia* spp. resistant to carbapenem antibiotics are increasingly reported. Meanwhile, *Dysgonomonas*, which belong to coccobacilli is a facultative anaerobic bacteria \[[@pone.0225873.ref048]\]. *Dysgonomonas* spp. is a major group represented in the gut microflora of BSFL, and *Bactrocera tau*. *Dysgonomonas* spp. isolated from human blood samples show antimicrobial susceptibility that directly inhibits competitors and potent pathogens from the same niche \[[@pone.0225873.ref049]\].

In this study, BSFL were determined to use the Duox-ROS immune system and Toll signaling pathway as a means of intestinal immune defense. Gene expression profiles of *BsfDuox* and *BsfTLR3* at different development times indicated that they may have key functions in host development. The role in immune defense of *Duox* and *TLR3* has been studied well, but their combined role in the regulation of intestinal microbial homeostasis and bacteriostasis is rarely reported. In this study, the silencing of the target gene *BsfDuox-TLR3* was successfully achieved for 4 days. The expression level of the *BsfDuox* was downregulated at 4--8 days of treatment, whereas that of the *BsfTLR3* was downregulated at 6--10 days of treatment. The maintenance of the RNAi effect in a short time is ideal for the study of changes in intestinal microflora homeostasis. Furthermore, silencing of the *BsfDuox-TLR3* gene in larvae led to the increase in density and changes in composition and diversity of intestinal indigenous bacterial community. This finding was similar with the report on the inactivation of *Duox* and intestinal bacterial reproduction in *B*. *dorsalis* \[[@pone.0225873.ref011]\].

At the 10-12^th^ day after dsRNA injection, the disordered intestinal bacterial community in turn stimulated BSFL *Duox-TLR3* gene expression and ROS production to suppress the overgrowth of non-symbiotic bacteria. Finally, at the 12^th^ day after dsRNA injection, BSFL*Duox-TLR3* gene regulated the structure and composition of the host intestinal bacterial community to a normal level. The relative proportion of dominant intestinal commensal bacteria *Dysgonomonas* and *Providencia* decreased, whereas that of *Lactococcus* and *Pseudomonadaceae* increased in *Duox-TLR3* RNAi-treated larvae at 4--8 days. *Dysgonomonas* and *Providencia* in the gut of BSF may enhance inhibition to *Salmonella* spp. and *S*. *aureus*, a significant decrease in *Dysgonomonas* and *Providencia* by *Duox-TLR3* silencing led to an adverse effect on the host \[[@pone.0225873.ref050]\]. Meanwhile, *Pseudomonadaceae* is a minor component in the BSF gut and includes four pathogenic bacteria, namely, *P*. *aeruginosa* \[[@pone.0225873.ref051]\], *Pseudomonas pertucinogena* \[[@pone.0225873.ref052]\], *Pseudomonas putida* \[[@pone.0225873.ref053]\], and *Pseudomonas fluorescens* \[[@pone.0225873.ref054]\]. *P*. *aeruginosa* is a human pathogen associated with human skin, mucous membrane, intestinal tract, and upper respiratory tract. The increase in *Pseudomonadaceae* caused by silencing of the *BsfDuox-TLR3* could cause toxicity to the host. Thus, silencing the *BsfDuox-TLR3* gene in the intestines allowed the increase of harmful bacteria.

The result may suggest that the depletion of these two immune genes in BSFL resulted in a proliferation of the minor pathogenic bacteria, which may have proven the potential decrease in anti-environmental pathogenic bacteria immune responses.Therefore, *BsfDuox* and *BsfTLR3* could regulate homeostasis by ensuring the stability of symbiotic bacteria and suppressing excessive growth of minor pathogen bacteria. Gut microbiome disorders are reminiscent of inflammatory bowel disease in humans, but intestinal symbiotes can also cause bowel disease under certain circumstance \[[@pone.0225873.ref055],[@pone.0225873.ref056]\]. In humans, many intestinal mucosal inflammatory diseases arise from abnormal intestinal and microbial relationships \[[@pone.0225873.ref057]\]. Therefore, the study on the role of BSFL *Duox-TLR3* gene in the homeostasis of intestinal bacterial community will provide reference for the further exploration of the maintenance mechanism of healthy intestinal microorganisms.

Overall, similar to humans, BSF larval intestine harbors a natural microbiota, participating in host metabolism and provide nutrients \[[@pone.0225873.ref058]\] as well as in the degradation of harmful substances \[[@pone.0225873.ref059]\] to protect the host from adverse factors such as natural enemies, parasites. In this study, a representative of the predominant gut immune gene *Duox-TLR3* from BSF showed antimicrobial activity that directly prevented the emergence and overgrowth of minor pathobionts. The mode of protection against an encountered pathogen was possibly due to the persistent immune responses involving free radicals and antibacterial peptides. By interfering with the *Duox-TLR3* gene, the intestinal bacterial richness and composition changed (*P*. *putida*, and *P*. *fluorescens*) to provoke chronic inflammation under dysbiosis conditions and weakened suppression on *S*. *aureus* and *Salmonella* spp.. Therefore, the natural bacterial flora is crucial to maintain the stable balance of intestinal microbial communities, resisting and eliminating foreign pathogenic bacteria for insect physiological ecology such as growth and development. Our results demonstrated that *BsfDuox* and *BsfTLR3* could regulate the gut key bacteria *Providencia* and *Dysgonomonas* homeostasis to depress zoonotic pathogens.
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###### Principal coordinate analysis based on weighted UniFrac metrics.

The result showed a separation of *ds-Duox-TLR3* and *ds-egfp-*treated samples along the first two axes, which explained 44.01% and 21.08% of the data variation, respectively. (A) 3Dscore plot of the *ds-Duox-TLR3* RNAi and *ds-egfp* RNAi sample (B) 2D biplots on PC1--PC2 plane overlapping scores and loadings.
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The paper brings important and new information and is highly relevant for the application of BSFL as waste converter, since waste streams can contain the pathogens under study. However, the language use was very poor and disappointing, and it reduced the readability of the paper. The many language errors deduct the reader from the content and devaluate the manuscript. As a reviewer, I corrected a number of language errors, but certainly not all of them. I strongly recommend professional language editing. On some places in the paper, statements were formulated too general and conclusions were drawn too strong in my opinion, i.e. based on evidence that was not substantial enough to make that conclusion. Also some elements are missing in the materials and methods section. I believe this manuscript can become a very meaningful paper as it contains interesting results but it needs major revisions.

Lines 17-19: "larvae can convert fresh pig manure into protein and fat-rich biomass, which can then be used as livestock feed Currently, 19 it is the only insect approved for such purposes in Europe". Please note that Hermetia is currently allowed in Europe for use in fish feed only, and not in feed for other animal species. In addition, even when used in aquafeed, the insect is not allowed to be reared on manure. Hence, lines17-19 are confusing and appear to say that much more is legally allowed in Europe than is currently the case. Please rephrase.

Line 21 "BSF larvae inhibit these zoonotic pathogens". Here to, the claim is too general: there are some indications in literature that show that larvae can inhibit growth of these pathogens, but these were only a number of occasions and this is certainly not yet demonstrated on all substrates and in all rearing conditions. A claim such as "BSF larvae inhibit these zoonotic pathogens" might give rearers and other stakeholders the idea that these pathogens, whenever present in the substrate will never be a problem. However, correct communication in sciences is needed to avoid misunderstandings and wrong conclusions in the insect sector. Please rephrase.

Line 28: "Providenciaand" and "Dysgonomonasintestinal": spaces are missing here. The same problem occurs at other places, too. Please check the whole manuscript yourself.

Line 40-41: "whose larvae consume various organic wastes of environmental concern". This is a strange formulation as it appears as if the larvae are looking for substrates with environmental concern. This is not the case. They can consume a wide range of substrates and this phenomenon can be applied in a positive way to feed them residues with environmental concern.

Line 52: Language problem. Replace "challenged larvae increased phenol oxidase" by "challenged larvae with increased phenol oxidase".

Line 54: Replace "To combat infection, insect relies on innate defense reactions to defense pathogens" by "To combat infection, the insect relies on innate defense reactions to inhibit pathogens".

Line 55: Replace "phenoloxidase" by "phenol oxidase".

Line 57: "GNBP3 and PGRP-SA": please clarify abbreviation.

Line 62 and following: the explanation of a Toll-like receptor as written here may not be clear to all readers. Please try to be more clear, for instance by replacing "Toll-like receptors (TLRs) are a class of type I membrane receptors with an extracellular amino terminus and a conserved cytoplasmic region. TLRs, which widely exist in antigen-presenting cells, are a pattern receptor involved in recognizing molecular structures (e.g., PAMPs) specific for microbial pathogens and have an important effect on innate and adaptive immune response." by "Toll-like receptors (TLRs) are proteins present in the membranes of cells that are part of the immune system and recognize invaders (sentinel cells). They are a class of type I membrane receptors with an extracellular amino terminus and a conserved cytoplasmic region. TLRs recognize specific molecular structures in microbial pathogens and this recognition activates innate and adaptive immune responses."

Line 66: "With routine microbial burdens, such as those found in the absence of infection, the Toll pathway at low activation levels." A verb is missing in this sentence.

Line 75: Replace "Microbial flora modulate" by "The microbiota modulates".

Line 78- 79: "to protect themselves against pathogenic microorganisms, such as bacteria and fungi". And what about entomopathogenic viruses?

Line 79: "Kumar et al. (2010) \[11\] and Mitochondria in Anopheles gambiae Giles (Diptera: Culicidae) intestinal cells and Enterobacter of intestinal bacteria": something is wrong with the construction of this sentence. I do not understand this sentence.

Line 88: "Recent surveys of black soldier fly gut microbiota revealed a diverse community dominated by Bacteroidetes and Proteobacteria\[15\]." Please include the following references here: <https://doi.org/10.1128/AEM.01864-18>, <https://doi.org/10.1007/s00248-018-1286-x>.

Line 102: replace "whether BSFL reduces suppression on zoonotic pathogens after BsfDuox-TLR3 RNA interference 104 (RNAi)" by whether suppression of zoonotic pathogens by BSFL is reduced after ...".

Line 110: Please include how you sterilized the feed (type of treatment and treatment parameters, such as time and temperature or radiation dose in the case of irradiation). If it was done by autoclavation, how did you make sure that nutrients for the larvae were not affected by the sterilization process? If no measurements were taken for this, can you guarantee that the growth of the larvae was normal after possible nutrient breakdown and that the model you study is representative for the large scale situation?

Line 111: what type of bran was use here? Wheat bran or from another cereal? Please make sure that your Materials and Methods are written in a way they can repeated by other researchers. For that reason, the type of bran should be specified.

Line 112: Please indicate the duration of each washing step so that other researchers can repeat the work.

Line 115: How was homogenisation performed? Equipment? Process parameters?

Line 120: "equal amounts of sterile distilled water": equal to what? How did you determine this? Please specify.

Line 124: please mention supplier of the medium, because the medium composition can differ (slightly) from one supplier to another.

Line 138: Did you perform the appropriate confirmation tests on the presumptive colonies as is to be done for Baird-Parker medium? If not, why not and how sure are you that you counted Staphylococcus aureus colonies? Can you exclude that non-Staphylococcus aureus colonies, present in the background microbiota, have also grown on the plates? In other words, how specific was your counting method?

Lines 130 to 136 and 145 to 150 are the same. Please avoid to copy-paste the text and replace lines 145 to 150 by mentioning that sample processing to perform the counts was performed in the same way for Salmonella as for Staphylococcus.

Line 154: same remark as for Staphylococcus: did you perform confirmation tests, as is a standard rule in microbiology?

Line 139 and 155: you mention results were expressed in cfu/g but in the figure you mention log cfu/g. Therefore, mention log cfu/g in your text as well.

Line 167: "data not published" Is this still correct? Why not refer to <https://doi.org/10.1038/s41422-019-0252-6?>

Line 178: "Third-instar larvae (8 days old) were fed with an artificial diet containing concentrated microbe solution (1×108 CFU/ml),": You mention the cell density of the inoculation suspension, but you do not mention how much of this solution was used per gram substrate. In this way, your method cannot be repeated by another researcher.

Line 184: "The resulting bacterial counts in each sample were adjusted to 1×108 CFU/ml by aseptic distilled water." As I understand, this means that you prepared the cell suspension, you plated and incubated it and then counted the colonies. How long did this step take? If it took a few days (for incubation), how can you be sure that in the suspension all cells remained alive? Typically in microbiology, to assess the inoculum size, turbidity is measured and a McFarland standard is prepared.

Line 185: "The larvae fed with a 5% sucrose diet only served as the control." Why did you use a sucrose as control? Can you exclude that the sucrose did not affect the growth and the intestinal microbiota of the larvae and hence that this was a good control? Please explain.

Line 188: "The microorganisms used in this study were pathogens S. aureus and Salmonella spp." This sentence is redundant because you mentioned this many times earlier in the text. Please delete the sentence.

Line 191: Is a sample of three larvae representative for the whole batch? Please prove so.

Line 195: Language problem. Replace "The amplification program was consist of" by The amplification program consisted of"

Line 208: What do you mean with "rapidly"? How long did the dissection of one larvae take maximally?

Line 209: "The dissected intestines were ground with PBS." Explain how. Can you assure that no ROS were lost during grinding?

Line 211: You mention that you measure the tissue and centrifuged it. Do you mean the ground tissue? If so, please add the word "ground".

Line 207 says you measured TOTAL in vivo ROS, but in Line 209 you say you took the dissected intestines. Can you be sure that ROS only occur in the intestines of the larvae and thus that by taking the intestines you indeed determine all ROS? Can there be ROS in other tissues of the larvae as well and would the title in Line 207 better be "Measurement of intestinal ROS"?

Line 224-225: "primer pairs used in dsRNA synthesis are shown in Supplemental Table 1.1 μg PCR product was used". Some words appear to be missing here: is 1.1 the number of the Table you refer to or is it the amount of PCR product used?

Line 281: "Each experiment was repeated three times". Formulated this way, a reader may think that each experiment was performed a first time, and then later, AFTER the first experiment a second time, and again later a third time and finally, after the third time a fourth time. This is was is meant with REPEATED three times. However, this is not consistent with what you write in Line 161, where you say that the experiment was PERFORMED three times. Please make sure this is consistent in your text.

Line 284: "Significant was set at p \< 0.05"; This is not a correct sentence. I guesse you mean "The significance level was set at p \< 0.05." (and ending the sentence with a point).

Line 300: "using the sterilized feed": Why did you do this experiment in sterile feed? Please explain this choice in the paper. Did you expect that the attenuation would not work when the feed would not be sterilized? What is the possible impact of the absence of the background microbiota in the feed on the results?

Line 304: Replace "BSFL reduced the inhibition of S. aureus at all time points, and the interference effect was maintained" by "the inhibition by the larvae of s. aureus was reduced at all time points and the effect was maintained", if this is what you mean.

Line 336: Replace "Infection of zoonotic pathogens" (which means that the pathogens get infected) by "Infection of zoonotic pathogens" (which means that the pathogens are infecting other organisms, here the larvae, I guess this is what you mean).

Line 366: "beneficial symbiont bacteria": your data are based on the statement that Providencia and Dysgonomonas are symbionts. I have two questions here: (1) provide ample references from literature that these genera are indeed symbionts for BSFL to prove your statement and (2) can you assure you did not miss other symbionts? What if there are other symbionts in BSFL that are not discovered or described yet and that you do not take into account and that react completely different than the two you mention in your study?

Line 367: Replace "decreased by 3.4% compared with" by "were 3.4% lower than".

Line 371: "the depletion of these two immune genes in BSFL reduced AMP and ROS production, leading to the decrease in symbiont bacteria and increase in pathogenic bacteria": It is clear that the reduced expression of these genes reduced AMP and ROS and in this way resulted in an increase in pathogenic bacteria. However, it is not clear to me that the reduction of the symbionts is a direct result of the reduced gene expression, as you seem to indicate. Could it be the case that the gene expression was reduced, that therefore that pathogens were not reduced and that as a consequence of that latter fact the symbionts could not dominate due to competitive exclusion by the outnumbering pathogens? In other words, the reduced expression leads to an increase in pathogens and this in its turn leads to a reduction in symbionts, and not (as you write) a reduced expression leading to a reduction in symbionts and this in its turn to an increase in pathogens. Please clarify very well what is cause and what is result.

Line 382: replace "were actively" by "were active".

Line 409: "At 4 days, Duox-TLR3 RNAi larvae with a decrease of 12% and 14.8%abundance of Providencia and Dysgonomonasthan control, respectively." Where is the verb in this sentence?

Line 413: what do you mean with "minor bacterial"? Please rephrase in proper English.

Line 418: Replace "a minor bacterium" by " a bacterium with low relative abundance".

Line 432: Replace "microbiota" by "microbiota".

Line 466: Replace "cell" by "cells".

Line 743: "By contrast, Duox inactivation leads to uncontrolled ??? of bacteria in the gut": it seems a word is missing here.

Line 484: Replace "domain" by "domains".

Line 506: Replace "B.Dorsalis" by "B. dorsalis".

Line 516: "BSF specifically belongs to the γ-proteobacteria". This is confusing since BSF is not a bacterium. Please rephrase in a correct way.

Line 519: "Enterobacteriaceae may plays". This sentence construction is not correct. Please reformulate.

Line 522: "Providencia spp. are gram-negative bacteria that was one of Enterobacteriaceae family". Sentence construction is not correct. Please reformulate.

Line 525: "which could resistant to". Same remark.

Line 525: "Meanwhile ..." This sentence is too long and difficult to read because it only ends at line 530. Please reformulate.

Line 536: Replace "P. Aeruginosa" by "P. aeruginosa".

Line 541: "By contrast, oriental BSF did not exhibit pathology associated with Pseudomonadaceae." Where do you have this information from? Please refer to literature to support this claim.

Reviewer \#2: In this manuscript Huang et al. analyze the role of Duox and Toll pathway in suppressing microbial pathogens in black soldier fly. By using different approaches the authors try to demonstrate that the two factors regulate pathogens by acting on the gut microbiota of the larva.

The mechanism used by the insect to discriminate resident bacteria from pathogen microorganisms is surely intriguing. Moreover the possibility to address this aspect in Hermetia illucens opens new applicative perspectives. However I think that the manuscript has many weak points:

a\. The presentation of results is quite confused and it is difficult to follow the flow of the experiments. A language revision is necessary and the paper is full of typos.

b\. The authors seem not to be aware of the current literature. Some examples:

\- many papers on BSF gut microbiota have been recently published (De Smet et al., 2018; Bruno et al., 2019; Jiang et al., 2019), while this article cites only a study on bacteria associated to BSF (Zheng on et al., 2013)

\- the authors do not mention a recent paper on BSF genome by the same research group (Zhan et al., 2019)

\- previous studies on BSF immune response have been overlooked (Vogel et al., 2018; Cickova et al., 2015)

c\. No information on the criteria for the choice of the bacterial concentrations administered to the larvae is reported.

d\. It is not clear why they used third instar larvae since this is a stage where Duox gene is weakly expressed.

e\. I'm concerned about the interpretation of some experiments. In fact the authors consider only some of the results to draw their conclusions, while others are completely overlooked. Some examples:

\- Figure 7B: 4 and 8 days have an opposite trend

\- Some data are discussed although not statistically significant

\- Salmonella spp. and S. aureus differently induce the expression of Duox gene

f\. The efficacy of RNAi in insects is strongly debated (see Scott et al., 2011; Terenius et al., 2011). This approach for gene silencing in Hermetia is new and there are no previous studies on this topic. Since most of the experiments of the current study are based on RNAi, further evidence is necessary to support qPCR data and demonstrate the efficacy of RNAi in this insect model.

g\. Duox and TLR3 genes have been cloned starting from a comparison with Drosophila homologs, but Discussion on these two proteins considers B. dorsalis.

h\. The authors should better argue why they focused attention on TLR3.

i\. Discussion needs to be focused. In addition, some aspects are not relevant to the current study (see structural characterization of Duox and TLR).

I. Supplementary information needs to be revised. For example Figure S8 is blurry and it is not possible to read the text.

Reviewer \#3: PONE-D-19-31548

Dual oxidase gene Duox and Toll-like receptor 3 gene TLR3 in the Toll pathway suppress zoonotic pathogens through regulating the intestinal bacterial community homeostasis in Hermetia illucens L.

Huang Y, et al.

Overall an interesting study. The manuscript has multiple small grammatical, spacing, tense and syntax errors, which make the manuscript difficult to read at points and require correction, some of which are listed below. The method section description is weak and requires further explanation and clarification. The statistical analyses in the results section require clarification as to how the analyses were done, how the data was grouped, as well why student T-test were done on time course data.

Materials and Methods

There is no validation of the sterilization method presented not a reference to a paper which validated the sterilization method. You assume that these larvae are sterilized, please present evidence for validation of this procedure. Please explain how larvae were sterilized, such as\... how long were larvae washed, were they agitated or just left to float, etc. Please explain how BSFL were exposed to the pathogen, you only explain state how the control was exposed. Also please give more detail, such as amount of solution mixed in the manure, how much manure and how it was introduced? Was it poured on top, mixed in, and at what temperature did exposure occur, how were they contained/what were they exposed in, etc.? Were only 60 larvae exposed or did you take 60 larvae from a large group (this is unclear the way it is stated). What is meant by "approximately", did you not count how many you dissected?

Please include website urls for references 20 and 21.

Line \#

This manuscript has many spacing errors.

54 - ...insects rely...to defend against...

77 - define Bd

80 -- How does Kumer et al (as a reference) increase ROS? This sentence does not make sense.

85 -- What is expression throughan? Again, poorly constructed sentence.

105 -- ...its relationship...

121 - ..replicated three times.

123 - A period is required "....detected\[20\]."

143 -- distilled water that was then stirred...

143 -- What is meant by "and used overnight"?

135, 150 -- What is meant by "Pathogen counts were determined using a selective enrichment."? Were the samples enriched first? If so, how were counts made?

154 - The mean Salmonella spp (CFU/g) of triplicate plates was determined.

159 - ... by using TRIzol... according to manufacturer instructions.

160 -- a full listing of the supply company used is required.

164; 194-- a full and accurate listing of the supplies and company used is required.

195 - ...amplification program consisted of...

205 -- there are multiple primers listed in this reference please be specific which primers were used.

290 -- what is meant by "in the natural environment" and "under normal pig manure conversion circumstances" this was not adequately explained in the methods.

Please use the same scale on your figures (1 and 2) so that they can directly be visually compared. Use a solid-no pattern for one of your data groups so they can be more easily distinguished form your pattern labels.

306 -- The graphs do support a complete loss of inhibitory effect until after 2 days. They do support a reduction in the inhibitory effect seen with Fig 1.

324 -- Be careful of your wording and punctuation, it appears you are saying the both Salmonella and Staph induced 4.05-times the Duos gene at 12 hours and this is not reflected in the graph.

325 - The same is true for this statement, make sure it is clear you are talking about Staph. The 24 hr increase is not shown on the graph? Put the significance designations directly above the error bars not at the top of the graph? Not sure students T-test is the proper analyses nor presentation by histogram. These were time courses, so you should be looking at the total time course differences via a line graph and an ANOVA (this would be true for all of your time course experiments presented in this manuscript. Also be clear in your statistical description what groups are being compared, in other words are you comparing only Staph to Staph at different time points or are you comparing all sample groups at the one time point to each other. This is not clear.

326 - I do not see on the graphs where Salmonella shows significant difference in Duox? Are you talking about 4 and 8 hours, if so where are the significance designations for Salmonella? Please clarify your statement.

340 -- Analyses for quantifying effector gene dif is not described in the Methods section; nor is cecropin, ubiquitin and stomoxyn.

349 & 352 -- An example that egfp RNAi and egfpRNAi is presented in these two different ways, with and without spacing. Be consistent throughout the manuscript. Also correct any capitalization of the species name (such as in Ln \# 506, 536).

382 -- active

Figures 8 and 9 -- the labels and legends are too small, and the resolution of the figures is too low. These require better quality graphics. Dendograms should be shown to demonstrate the relatedness of the community composition.

409 -- incomplete sentence.

420 -- Where did you demonstrate that the relative abundance of Comamonas was directly tied to reduced ROS and AMP?

Fig 8 -- Again keep axis values the same so direct comparisons can be made. Put significance markers on these graphs.

429 -- Tie these last three sentences in better to the immune expression theme and the observations in your study.

461 -- This is true only at Day 8 and with Chao and ACE. So this blanket statement is incorrect.

471 -- fix spacing

473 - What does ...uncontrolled of bacteria in the gut... mean?

516 - ...belonging...

518 - ...could potentially...

520 - ...play...

522, 524, 525-528, 562 -- poor sentence structure

531 -- need a reference

389, 424, 438, 446, 498, 549 -- avoid the first person "We"

Reviewer \#4: • The following statement from the abstract is misleading: "Currently, it is the only insect approved for such purposes in Europe, Canada, and the USA". A number of other species of insects can be legally used for feeding animals.

• Line 274: The R packages used should be cited in accordance with R software citation practices. These proper citation can be found in the software library.

• Line 316-319: why would these genes be less expressed at specific intermediary instars? What could be the explanation for that?

• Line 328-331: These results show that gene expression is increased. When the genes do express you refer to a plot where you show the increase in H202, but don't discuss this in the text.

• Could the authors explain more clearly the mechanism by which the gene expression reduces the microbial load? Is it only H2O2, or was that the only measurable bioactive compound?

• Is there any insight into how activation of these genes reduces activation of other genes as a tradeoff, that might reduce growth performance in farming? In other words, what is the burden on the animal? Is this later described in line 438?

• Lines 349-375 show what as observed regarding time to recover expression of certain genes. Could the authors explain why the larvae needs the length of time observed to recover from silencing? What activities are underway that take the observed number of days to recover normal activity? Maybe this is explained in Lines 376-386, but it is not written in a way that is clear to me if this connection is being made.

• Line 432: a comparison is made to mosquitos. I find these types of comparisons relevant since they show how BSF act compared to other species. More clear comparisons with other species and how they react, especially quantitative ones, would be welcome. In particular, it would be very valuable to see how much H202 BSF produce relative to other members of Diptera under similar conditions. Do we see much higher output, which corresponds to their well-known robustness at the larval stage?

• Much is made of BSF's ability to manage pathogens in industry. Could you please use part of the discussion to give direction to where more work needs to be done to confirm if the ability of BSF to reduce pathogens can be relied upon to produce safe raw larvae for the feed and food industries? Or can you explain how your results show that BSF will not be able to completely resolve a serious safety issue and that other steps will be needed, like heat treatment.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

Reviewer \#4: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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11 Feb 2020

Dear Editor,

Journal of PLoS One

Kindly refer to your email sent on 2019/12/30 regarding the reviewers' comments on our manuscript ID WM-19-31548 entitled \"Dual oxidase Duox and Toll-like receptor 3 TLR3 in the Toll pathway suppress zoonotic pathogens through regulating the intestinal bacterial community homeostasis in Hermetia illucens L.\". Based on his/her kind comments, we have carefully modified the manuscript. We submit the manuscript with track and no track version according to you requirements. The sequencing data of black soldier fly larvae gut bacteria 16S rDNA high-throughput sequencing has been uploaded. Serial number of original sequence data: bioprojectID PRJNA600829 and SRP247530 were added in Materials and Methods section of text. We have thoroughly revised as per suggestions of reviewers. The English language has been revised by a native English speaker scientist Professor Jeffery K. Tomberlin from Texas A &M University, USA .Thank you very much for the encouragement and providing very useful suggestions to improve the quality of our manuscript. We hope that the revised-manuscript now will meet the standards for publication in your esteemed journal.

###### 

Submitted filename: Response to reviewers.docx
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Click here for additional data file.
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25 Feb 2020

PONE-D-19-31548R1

Dual Oxidase Duox and Toll-like receptor 3 TLR3 in the Toll pathway suppress zoonotic pathogens through regulating the intestinal bacterial community homeostasis in Hermetia illucens L.

PLOS ONE

Dear Dr. Zhang,

Thank you for submitting your revised manuscript to PLOS ONE.

Reviewer has major reservation about your work. I side with this reviewer and would give you one final opportunity to revise your paper further. Failure to satisfy the reviewer fully might result in rejection of your further revised paper.

We invite you to submit a revised version of the manuscript that addresses the points raised during the second round of review.

We would appreciate receiving your revised manuscript by Apr 10 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Dong-Yan Jin

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: This is the revised version of a manuscript by Huang et al. in which the authors analyzed the role of Duox and Toll pathway in controlling microbial pathogens in Hermetia illucens.

Although the authors improved the manuscript and the text is now more fluent, they did not really address most of the questions raised during the first revision. Moreover some of their answers are cryptic. Some examples:

a\. Bacterial concentration. Yao Z. et al., 2016 is a study on B. dorsalis, a different insect species. Why did the authors refer to this paper for their experiments on BSF? Did they perform preliminary assays in BSF to demonstrate that "low concentrations of bacteria cannot activate the immune system", as stated in the rebuttal letter?

b\. I still do not understand why third instar larvae were used (see answers as "four instar larvae were feathered"??? "fifth instar larvae were too old to take out the intestine"???)

c\. Interpretation of some experiments. I do not see any information in the new text about the points that I indicated in the previous revision (see trend of some markers, statistics, expression of Duox gene, etc.)

d\. RNAi. The authors just say that RNAi works in Drosophila, they declare to be able to use Crispr/cas9 gene editing in Hermetia and that they could not do any additional experiments since one of them left the laboratory. What does this mean? This does not reply to my question on RNAi. This is the first report on the use of RNAi in BSF, thus I think that this aspect is worthy of a deeper investigation.

e\. Some of the revised points indicated in the cover letter are not present in the text (see for example L518 for B. dorsalis or L66 for TLR3)

f\. Although Discussion has been revised, it still contains some information that, in my opinion, it not relevant to the current study (see for example structural characterization of Duox and TLR). Moreover, I'm still convinced that the whole section should be more focused.

g\. Many typos are still present in the text.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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25 Mar 2020

Response to reviewer 2 comments

a.Bacterial concentration. Yao Z. et al., 2016 is a study on B. dorsalis, a different insect species. Why did the authors refer to this paper for their experiments on BSF? Did they perform preliminary assays in BSF to demonstrate that "low concentrations of bacteria cannot activate the immune system", as stated in the rebuttal letter?

Response: Thank your good question. Because Hermetia illucens and B. dorsalis is close relatives and both belong to Diptera. Their BsfDuox and BsfTLR3 were similar. They did not perform preliminary assays in BSF to demonstrate that "low concentrations of bacteria cannot activate the immune system". We just did some preliminary experiments to explore the suitable concentrations of bacteria for BSFL infect treatment.

b.I still do not understand why third instar larvae were used (see answers as "four instar larvae were feathered"??? "fifth instar larvae were too old to take out the intestine"???)

Response: The third instar is the right size to pull out the intestines. The other larvae are either too small or have no intestines to pull out.

c.Interpretation of some experiments. I do not see any information in the new text about the points that I indicated in the previous revision (see trend of some markers, statistics, expression of Duox gene, etc.

Response: Thanks for your suggestion, we have revised it in text(L130-133, L154-L155, L164-171, L183-L184, L190-L193, L199-L203, L212-L213, L224, L228-L229, L233-L236, L239-240, L245-L246, L247-L254, L270-L271, L283, L327-L328).

d.RNAi. The authors just say that RNAi works in Drosophila, they declare to be able to use Crispr/cas9 gene editing in Hermetia and that they could not do any additional experiments since one of them left the laboratory. What does this mean? This does not reply to my question on RNAi. This is the first report on the use of RNAi in BSF, thus I think that this aspect is worthy of a deeper investigation.

Response: Our experiment is to study the black soldier flies, using crisper-cas system and RNAi technology to interfere the genes of BSF have achieved good results(Zhan et al 2019). RNAi technology worked well in Drosophila and Caenorhabditis elegans. Schistocerca americana et al. RNAi also has drawbacks and obscure points, However, such as those related to differences in species sensitivity,there are hundreds of research papers to prove the effectiveness of RNAi in insects. The QPCR test could verify the RNAi results, each QPCR experiment was repeated three times.

e:Some of the revised points indicated in the cover letter are not present in the text (see for example L518 for B. dorsalis or L66 for TLR3)

Response: Thank you for your suggestion. In L518 I wrote Enterobacteriaceae bacteria instead of a B. dorsalis ,which appears in the cover letter. In L66 I wrote TLR3,which also appears in the cover letter.

f:Although Discussion has been revised, it still contains some information that, in my opinion, it not relevant to the current study (see for example structural characterization of Duox and TLR). Moreover, I'm still convinced that the whole section should be more focused.

Reponse: Thank you for your suggestion. We have deleted not relevant contents in discussion section such as structural characterization of Duox and TLR and other not relevant information(L549，L599-L603，L621-L627，L643).

g: Many typos are still present in the text.

Reponse: Thanks for your suggestion, We have double checked and revise it in whole text(L535，L539 ,L663-L888 et al.).

###### 

Submitted filename: Response to Reviewers.docx

###### 

Click here for additional data file.
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Dear Dr. Zhang,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Dong-Yan Jin

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

10.1371/journal.pone.0225873.r006

Acceptance letter

Jin

Dong-Yan

Academic Editor

© 2020 Dong-Yan Jin

2020

Dong-Yan Jin

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

3 Apr 2020

PONE-D-19-31548R2

Dual Oxidase *Duox* and Toll-like receptor 3 *TLR3* in the Toll pathway suppress zoonotic pathogens through regulating the intestinal bacterial community homeostasis in *Hermetia illucens* L.

Dear Dr. Zhang:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.
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